A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1

Progress towards the development of a malaria vaccine against Plasmodium vivax, the most widely distributed human malaria parasite, will require a better understanding of the immune responses that confer clinical protection to patients in regions where malaria is endemic. The occurrence of clinical...

Full description

Saved in:
Bibliographic Details
Main Authors: Nogueira, Paulo Afonso, Piovesan Alves, Fabiana, Fernandez-Becerra, Carmen, Pein, Oliver, Rodrigues Santos, Neida, Pereira da Silva, Luiz Hildebrando, Plessman Camargo, Erney, del Portillo, Hernando A.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2006
Subjects:
Microbial Immunity and Vaccines
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1459730/
https://ncbi.nlm.nih.gov/pubmed/16622209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.74.5.2726-2733.2006
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items